EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
75 hedge funds and large institutions have $297M invested in ESSA Pharma in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less capital invested
Capital invested by funds: $976M → $297M (-$679M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
75
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$20.6M | |
| 2 | +$11.7M | |
| 3 | +$8M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$5.47M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.04M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$10.4M | |
| 3 | -$9.96M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$9.48M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$8.32M |